Skip to main content
. Author manuscript; available in PMC: 2013 Jun 15.
Published in final edited form as: Biochem Biophys Res Commun. 2012 May 16;422(4):561–567. doi: 10.1016/j.bbrc.2012.05.024

Fig. 3.

Fig. 3

CDDO-Me inhibits telomerase activity. (A) Measurement of telomerase activity. MiaPaCa-2 and Panc-1 cells were treated with CDDO-Me (0–10 μM) for 48 h and telomerase activity of cell extracts was measured by TRAP assay as described in Section 2. (A and C) DNA laddering patterns under different treatment conditions. (B and D) Quantification of telomerase activity in (A) and (C). Experiments were repeated two times. NC, negative control (no cell extract).

HHS Vulnerability Disclosure